First Success Reported Of Targeted Th...

First Success Reported Of Targeted Therapy In Most Common Non-Small Cell Lung Cancer

There are 1 comment on the MediLexicon story from Nov 30, 2012, titled First Success Reported Of Targeted Therapy In Most Common Non-Small Cell Lung Cancer. In it, MediLexicon reports that:

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Join the discussion below, or Read more at MediLexicon.

Since: Dec 05

Reading, PA

#1 Dec 1, 2012
Patients with NSCLC with KRAS mutations have no effective empirical treatment strategy for the "individual." Previous clinical trials have found out that targeted drugs were more active when combined with traditional lung cancer treatments and other investigational targeted therapies that target a MEK inhibitor or a PI3K/mTOR inhibitor, etc.

One approach to this problem is to functionally target "multiple" pathways in a cancer cell. Another challenge is to identify which of the targeted treatments will be effective (enzyme inhibitors, proteasome inhibitors, angiogenesis inhibitors, and monoclonal antibodies).

It's going to require multiple drugs administered in combination targeted to abnormal patterns of cellular machinery that effect or reflect malignant behavior, to have any true effect. The solution is "combination" therapy to attack all the different targets there are (or at least they know there are). The "target" is the set of all malignant cells that could evolve.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

DanaFarber Cancer Institute Discussions

Title Updated Last By Comments
News Study offers genetic explanation why cancer occ... Nov '16 Stephany McDowell 1
News High vitamin D levels increase survival of pati... (Jan '15) Jan '15 Gerald Vonberger 1
News Corruption Alleged in Massachusetts' Top Courts (Mar '13) Mar '13 Aliana BEvonRicht... 1
News Rheumatoid Arthritis Prevented in Mice (Feb '13) Feb '13 gdeborah 2
News amfAR Funds Innovative Approaches to HIV Research (Jan '13) Jan '13 Anonymous 1
News Study: Aspirin may extend survival for some col... (Oct '12) Oct '12 HumanSpirit 2
News 40 years on, the triumphs and challenges of Ame... (Dec '11) Dec '11 Walden Strom 2
More from around the web